Does IPILIMUMAB Cause Embolism? 72 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 72 reports of Embolism have been filed in association with IPILIMUMAB (YERVOY). This represents 0.2% of all adverse event reports for IPILIMUMAB.
72
Reports of Embolism with IPILIMUMAB
0.2%
of all IPILIMUMAB reports
22
Deaths
59
Hospitalizations
How Dangerous Is Embolism From IPILIMUMAB?
Of the 72 reports, 22 (30.6%) resulted in death, 59 (81.9%) required hospitalization, and 9 (12.5%) were considered life-threatening.
Is Embolism Listed in the Official Label?
Yes, Embolism is listed as a known adverse reaction in the official FDA drug label for IPILIMUMAB.
What Other Side Effects Does IPILIMUMAB Cause?
Death (3,710)
Malignant neoplasm progression (3,296)
Diarrhoea (2,557)
Off label use (2,097)
Colitis (1,988)
Pyrexia (1,796)
Rash (1,556)
Fatigue (1,447)
Intentional product use issue (1,329)
Nausea (1,169)
What Other Drugs Cause Embolism?
BEVACIZUMAB (378)
PACLITAXEL (251)
LENALIDOMIDE (206)
DEXAMETHASONE (204)
RITUXIMAB (204)
CYCLOPHOSPHAMIDE (202)
DOXORUBICIN (198)
RIVAROXABAN (197)
CARBOPLATIN (187)
APIXABAN (181)
Which IPILIMUMAB Alternatives Have Lower Embolism Risk?
IPILIMUMAB vs IPRAGLIFLOZIN L-PROLINE
IPILIMUMAB vs IPRATROPIUM
IPILIMUMAB vs IPRATROPIUM\IPRATROPIUM ANHYDROUS
IPILIMUMAB vs IPTACOPAN
IPILIMUMAB vs IRBESARTAN